Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | REC-7735 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on REC-7735, a putative PIK3CA H1047R inhibitor (Nov 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| REC-7735 | REC7735|REC 7735 | PIK3CA inhibitor 30 | Limited information is currently available on REC-7735, a putative PIK3CA H1047R inhibitor (Nov 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07819136 | Phase Ib/II | REC-7735 | REC-7735 in Participants With Solid Tumors | Recruiting | USA | 0 |